Related Experiment Video

Updated: Jun 24, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

[Systemic inflammation and atherosclerosis of common carotid arteries in patients with chronic obstructive pulmonary

E N Chicherina, O V Miliutina

    Klinicheskaia Meditsina
    |April 8, 2009
    PubMed

    Insights

    Systemic inflammation drives atherosclerosis in patients with Chronic Obstructive Pulmonary Disease (COPD), with or without arterial hypertension (AH). Elevated C-reactive protein and intima-media thickness (IMT) indicate disease progression.

    Area of Science:

    • Cardiovascular Medicine
    • Pulmonology
    • Inflammation Research

    Background:

    • Chronic Obstructive Pulmonary Disease (COPD) and arterial hypertension (AH) are significant health concerns.
    • Systemic inflammation is implicated in the pathogenesis of cardiovascular diseases.
    • The interplay between COPD, AH, and atherosclerosis requires further investigation.

    Purpose of the Study:

    • To investigate the effect of systemic inflammation on endothelial function and carotid artery atherosclerosis in patients with COPD.
    • To compare these effects in patients with COPD alone versus those with COPD and co-existing arterial hypertension.
    • To explore the relationship between inflammatory markers and atherosclerosis progression.

    Main Methods:

    • Study included 51 men, categorized into COPD with AH, isolated AH, isolated COPD, and a control group.
    • Measurements included intima-media thickness (IMT) of common carotid arteries, serum C-reactive protein levels, and blood lipid profiles.
    • Statistical analysis was performed to assess correlations between inflammatory markers, IMT, and disease status.

    Main Results:

    • Patients with COPD, both with and without AH, exhibited atherosclerosis of the common carotid arteries.
    • Persistent systemic inflammation was identified as a key factor contributing to atherosclerosis in these patients.
    • Increased serum C-reactive protein and IMT were significantly associated with the initiation and progression of atherosclerosis.

    Conclusions:

    • Systemic inflammation plays a crucial role in the development of atherosclerosis in COPD patients, irrespective of arterial hypertension.
    • Elevated C-reactive protein and IMT serve as indicators of ongoing atherosclerotic processes in this population.
    • These findings highlight the importance of managing systemic inflammation in COPD patients to mitigate cardiovascular risk.

    Related Concept Videos

    Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

    Chronic Obstructive Pulmonary Disease-II: Pathophysiology

    Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
    Chronic Inflammation
    Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

    Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

    Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
    Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

    Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

    Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
    Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
    Primary Symptoms of COPD:
    Chronic Obstructive Pulmonary Disease I: Introduction01:23

    Chronic Obstructive Pulmonary Disease I: Introduction

    Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
    Chronic Obstructive Pulmonary Disease01:24

    Chronic Obstructive Pulmonary Disease

    COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
    Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
    Chronic Obstructive Pulmonary Disease-I: Introduction01:20

    Chronic Obstructive Pulmonary Disease-I: Introduction

    Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.